Skip to main content
SpringerLink
Log in

Literatur

  • Chapter
Herzinsuffizienz

Part of the book series: Edition Ärztewoche ((EDITÄRZTE))

  • 1687 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 24.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 34.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chait B, Fromer M, et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 27: 2099–2140

    Article  PubMed  Google Scholar 

  2. The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda F, Tavazzi L, Smiseth OA, ESC Committee for Practice Guidelines (CPG), Priori S (Chairperson) (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J 26: 1115–1140

    Article  PubMed  CAS  Google Scholar 

  3. Nieminen MS, Böhm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, ESC Committee for Practice Guidelines (CPG), Priori SG, Blanc J-J, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Alonso Garcia MA, (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. The Task Force on Acute Heart Failure of the European Society of Cardiology Endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 26: 384–416

    Article  PubMed  Google Scholar 

  4. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, Grobbee DE (1997) The epidemiology of heart failure. Eur Heart J 18: 208–225

    PubMed  CAS  Google Scholar 

  5. Grimm G, Pacher R, Weber H (2006) Consensus Herzinsuffizienz — State of the Art 2006. Österr Ärztezeitung [Suppl]: 3–15

    Google Scholar 

  6. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ (2001) More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Failure 3: 315–322

    Article  CAS  Google Scholar 

  7. Hunt SA, Antman EM, et al (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46: 1116–1143

    Article  Google Scholar 

  8. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, et al (2006) Systolic and diastolic heart failure in the community. JAMA 296: 2209–2216

    Article  PubMed  CAS  Google Scholar 

  9. Vasan RS, Levy D (1996) The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. Framingham Heart Study, Mass, USA. Arch Intern Med 156: 1789–1796

    Article  PubMed  CAS  Google Scholar 

  10. Kjekshus J (1990) Arrhythmias and mortality in congestive heart failure. Am J Cardiol 65: 42I–48I

    Article  PubMed  CAS  Google Scholar 

  11. Hoppe UC, Böhm M, Dietz R, Hanrath P, Kroemer HK, Osterspey A, Schmaltz AA, Erdmann E (2005) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 94: 488–509

    Article  PubMed  CAS  Google Scholar 

  12. Binkley PF, Lesinski A, Pohorence Ferguson J, Hatton PS, Yamokoski L, Hardikar S, Cooke GE, Leier CV (2008) Recovery of normal ventricular function in patients with diated cardiomyopathy: predictors of an increasingly prevalent clinical event. Am Heart J 155: 69–74

    Article  PubMed  Google Scholar 

  13. Opie LH (2004) Heart physiology, from cell to circulation, 4th edn. Lippincott Williams and Wilkins Comp, pp 506–507

    Google Scholar 

  14. Hildebrandt P (2006) Systolic and nonsystolic heart failure — equally serious threats. JAMA 296: 2259–2260

    Article  PubMed  CAS  Google Scholar 

  15. Manning HL, Schwartzstein RM (1995) Pathophysiology of dyspnea. N Engl J Med 333: 1547

    Article  PubMed  CAS  Google Scholar 

  16. Redfield MM, Jacobsen SL, Burnett JC Jr, Mahoney BW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289: 194–202

    Article  PubMed  Google Scholar 

  17. Badgett RG, Lucey CR, Mulrow CD (1997) Can the clinical examination diagnose left-sided heart failure in adults? JAMA 277: 1712–1719

    Article  PubMed  CAS  Google Scholar 

  18. Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, Huddleston M, McCulloch CE, Foster E, Chatterjee K, Michaels AD (2005) Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function. JAMA 293: 2238–2244

    Article  PubMed  CAS  Google Scholar 

  19. Moe GW (2006) B-type natriuretic peptide in heart failure. Curr Opin Cardiol 21: 208–214

    PubMed  Google Scholar 

  20. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AHB, Clopton P, Steg PG, Westheim A, Wold Knudsen C, Perez A, Kazanegra R, Herrmann HC, Mc-Cullough PA, for the Breathing Not Properly Multinational Study Investigators (2002) Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161–167

    Article  PubMed  CAS  Google Scholar 

  21. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP (2004) Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350: 647–654

    Article  PubMed  CAS  Google Scholar 

  22. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Cohen Solal A (2004) Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after de-compensated heart failure. J Am Coll Cardiol 43: 635–641

    Article  PubMed  CAS  Google Scholar 

  23. Wu AH (2006) Serial testing of B-type natriuretic peptide and NT-proBNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J 152: 828–834

    Article  PubMed  CAS  Google Scholar 

  24. Schou M, Gustafsson F, Nielsen PH, Madsen LH, Kjaer A, Hildebrandt PR (2007) Unexplained week-to-week variation in BNP and NT-proBNP is low in chronic heart failure patients during steady state. Eur J Heart Failure 9: 68–74

    Article  CAS  Google Scholar 

  25. Zannad F, Huvelle E, Dickstein K, van Veldhuisen DJ, Stellbrink C, Kober L, Cazeau S, Ritter P, Maggioni AP, Ferrari R, Lechat P (2007) Left bundle branch block as a risk factor for progression to heart failure. Eur J Heart Failure 9: 7–14

    Article  Google Scholar 

  26. Kashani A, Barold SS (2005) Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 46: 2183–2192

    Article  PubMed  Google Scholar 

  27. McMurray JJ, Stewart S (2000) Epidemiology, aetiology and prognosis of heart failure. Heart 83: 596–602

    Article  PubMed  CAS  Google Scholar 

  28. Fuster C, Rydén LE, Asinger RW, Cannom DS, Crijns HJ (2006) ACC/AHA/ESC Guidelines 2006 for the managmenet of patients with atrial fibrillation — Executive summary. Eur Heart J 27: 1979–2030

    Article  PubMed  Google Scholar 

  29. Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ, Tsang TS (2006) Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 47(12): 2357–2363

    Article  PubMed  Google Scholar 

  30. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) (1999) Lancet 353: 2001–2007

    Article  Google Scholar 

  31. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350: 2151–2158

    Article  PubMed  CAS  Google Scholar 

  32. Opie LH (2004) Heart physiology, from cell to circulation, 4th edn. Lippincott Williams and Wilkins, p 463

    Google Scholar 

  33. Task Force of the European Society of Cardiology, in Collaboration with the Association of European Paediatric Cardiologists (1998) The clinical role of magnetic resonance in cardiovascular disease. Eur Heart J 19: 19–39

    Article  Google Scholar 

  34. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. CMAJ 132: 919–923

    CAS  Google Scholar 

  35. Kervio G, Ville NS, Leclercq C, Daubert JC, Carre F (2005) Use of the six-minute walk test in cardiology. Arch Mal Coeur Vaiss 98: 1219–1224

    PubMed  CAS  Google Scholar 

  36. Gaul GB (1999) Quality of life — Therapieziel oder Schlagwort? J Kardiol 6: 617–621

    Google Scholar 

  37. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348: 2007–2018

    Article  PubMed  Google Scholar 

  38. Friedrich EB, Böhm M (2007) Management of end stage heart failure. Heart 93: 626–631

    Article  PubMed  Google Scholar 

  39. The Task Force on ACE-Inhibitors of the European Society of Cardiology. Lopez-Sendon J, Karl Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C, Priori SG, Alonso Garcıa MA (2004) Expert consensus document on Angiotensin converting enzyme inhibitors in cardiovascular disease. Eur Heart J 25: 1454–1370

    Article  PubMed  Google Scholar 

  40. The Task Force on Beta-Blockers of the European Society of Cardiology. Lopez-Sendon J, Karl Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C, Priori SG, AlonsoGarcıa MA (2004) Expert consensus document on b-adrenergic receptor blockers. Eur Heart J 25: 1341–1362

    Article  PubMed  Google Scholar 

  41. Mielniczuk L, Warner Stevenson L (2005) Angiotensin-converting enzyme inhibitors and angiotensin II type I receptor blockers in the management of congestive heart failure patients: what have we learned from recent clinical trials? Curr Opin Cardiol 20: 250–255

    PubMed  Google Scholar 

  42. Lewis EF, Lamas GA, O’Meara E, Granger CB, et al; for the CHARM Investigators (2007) Characterisation of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail 9: 83–91

    Article  PubMed  Google Scholar 

  43. Sirak TE, Jelic S, Le Jemtel TH (2004) Therapeutic update: Non-selective beta-and alpha-adrenergic blockade in heart failure patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J Am Coll Cardiol 44: 497–502

    Article  PubMed  CAS  Google Scholar 

  44. Yan AT, Yan RT, Liu PP (2005) Narrative review: pharmacotherapy for chronic heart failure: evidence from recent clinical trials. Ann Intern Med 142: 132–145

    PubMed  CAS  Google Scholar 

  45. Opie LH (2004) Heart physiology, from cell to circulation, 4th edn. Lippincott Williams and Wilkins, p 504

    Google Scholar 

  46. Sica DA (2006) Sodium and water retention in heart failure and diuretic therapy: basic mechanisms. Clev Clin J Med 73[Suppl 2]: S2–S7

    Article  Google Scholar 

  47. Swedberg K, Andersson B, Leclercq C, Turina M (2006) Management of chronic heart failure. In: Camm AJ, Lüscher TF, Serruys PW (eds) The ESC textbook of cardiovascular medicine. Blackwell Publishing, pp 721ff

    Google Scholar 

  48. Adrogue HJ (2000) Hyponatremia. N Engl J Med 342: 1581–1589

    Article  PubMed  CAS  Google Scholar 

  49. Lüderitz B (1993) Geschichte der Herzrhythmusstörungen. Springer, ISBN 3540562087, S 119ff

    Google Scholar 

  50. The Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336: 525–533

    Article  Google Scholar 

  51. deGoma EM, Vagelos RH, Fowler MB, Ashley EA (2006) Emerging therapies for the management of decompensated heart failure. From Bench to Bedside. J Am Coll Cardiol 48: 2397–2409

    Article  PubMed  CAS  Google Scholar 

  52. Rossi J, Bayram M, Udelson JE, Lloyd-Jones D, Adams KF, Oconnor CM, Stough WG, Ouyang J, Shin DD, Orlandi C, Gheorghiade M (2007) Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Card Care 9(2): 82–6

    Article  PubMed  Google Scholar 

  53. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RH; Ip JH for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352: 225–237

    Article  PubMed  CAS  Google Scholar 

  54. Steger Ch, Pratter A, Martinek-Bregel M, Avanzini M, Valentin A, Slany J, Stöllberger C (2004) Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry. Eur Heart J 25: 1734–1740

    Article  PubMed  Google Scholar 

  55. Crijns HJGM, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP, van Veldhuisen DJ (2000) Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 21: 1238–1245

    Article  PubMed  CAS  Google Scholar 

  56. Gage BF, van Walraven C, Pearce L (2004) Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110: 2287–2292

    Article  PubMed  CAS  Google Scholar 

  57. Hart RG, Benavente O, McBride R, Pearce LA (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131: 492–501

    PubMed  CAS  Google Scholar 

  58. Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, Budaj A, Gulba DC, Allegrone J, Brieger D for the GRACE Investigators (2007) Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 28: 1717–1722

    Article  PubMed  CAS  Google Scholar 

  59. The Atrial Fibrillation Follow up Investigation of Rhythm Management (AFFIRM) Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347: 1825–1833

    Google Scholar 

  60. Lip GYH, Tello-Montoliu A (2006) Management of atrial fibrillation Heart 92: 1177–1182

    Article  PubMed  Google Scholar 

  61. Gall NO, Murgatroyd FD (2007) Electrical cardioversion for AF — the state of the art. PACE 30: 554–567

    PubMed  Google Scholar 

  62. Deakin CD, Nolan JP (2005) European Resuscitation Council Guidelines for Resuscitation 2005 Section 3. Electrical therapies: Automated external defibrillators, defibrillation, cardioversion and pacing. Resuscitation 67S1: S25–S37

    Article  Google Scholar 

  63. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chait B, Fromer M, et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. A report of the American College of Cardiology/American Heart AssociationTask Force and the European Society of Cardiology Committee for Practice Guidelines. Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 746–837

    Article  PubMed  Google Scholar 

  64. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML for the MADIT-II Investigators (2004) Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 43: 1459–1465

    Article  PubMed  Google Scholar 

  65. Forrester JS, Diamond GA, Swan HJ (1977) Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol 39: 37–145

    Article  Google Scholar 

  66. Yuksel Cavusoglu (2007) The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure. Expert Opin Pharmacother 8: 665–677

    Article  PubMed  CAS  Google Scholar 

  67. Goldberg LR, Jessup M (2006) Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction. Circulation 113: 2851–2860

    Article  PubMed  Google Scholar 

  68. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS (2003) Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108: 977–982

    Article  PubMed  Google Scholar 

  69. Cleland JGF, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, for the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology, Freemantle N, Eastaugh J, Mason J (2003) The EuroHeart Failure survey programme — a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 24: 442–463

    Article  PubMed  CAS  Google Scholar 

  70. Singh SN, Carson PE, Fisher SG (1997) Nonsustained ventricular tachycardia in severe heart failure. Circulation 96: 3794–3795

    PubMed  CAS  Google Scholar 

  71. Lane RE, Cowie MR, Chow AWC (2005) Prediction and prevention of sudden cardiac death in heart failure. Heart 91: 674–680

    Article  PubMed  Google Scholar 

  72. Priori SG, Aliot E, Blømstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm JA, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJJ, Zipes DP (2001) Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22: 1374–1450

    Article  PubMed  CAS  Google Scholar 

  73. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL (2002) ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) Circulation 106: 2145–2161

    Article  PubMed  Google Scholar 

  74. Lemke B, Nowak B, Pfeiffer D (2005) Leitlinien zur Herzschrittmachertherapie. Z Kardiol 94: 704–720

    Article  PubMed  CAS  Google Scholar 

  75. Hochleitner M, Hörtnagl H, Ng CK, Hörtnagl H, Gschnitzer F, Zechmann W (1990) Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 66: 198–202

    Article  PubMed  CAS  Google Scholar 

  76. Zweng A, Gulesserian M, Gregor D, Weber H (2006) Schrittmachertherapie bei Vorhofflimmern. J Kardiol 13: 15–20

    Google Scholar 

  77. Jung W, Andresen D, Block M, Böcker D, Hohnloser SH, Kuck KH, Sperzel J (2006) Leitlinien zur Implantation von Defibrillatoren. Clin Res Cardiol 95: 696–708

    Article  PubMed  CAS  Google Scholar 

  78. Cheuk-Man Yu, Chau E, Sanderson JE, Katherine Fan K, Man-Oi Tang, Wing-Hong Fung, Hong Lin, Shun-Ling Kong, Yui-Ming Lam, Hill MRS, Chu-Pak Lau (2002) Tissue doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 105: 438–445

    Article  Google Scholar 

  79. Vollmann V, Nägele H, Schauerte P, Wiegand U, Butter C, Zanotto G, Quesada A, Guthmann A, Hill MRS, Lamp B; for the European InSync Sentry Observational Study Investigators (2007) Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure Eur Heart J 28: 1835–1840

    Article  PubMed  Google Scholar 

  80. Badhwar V, Bolling SF (2003) Nontransplant surgical options for heart failure in cardiac surgery in the adult. In: Edmunds LH, Cohn LH (eds) Mc-Graw-Hill Professional, ISBN: 0071391290, pp 1515–1526

    Google Scholar 

  81. Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, Sadowski Z, Golba KS, Prior DL, Rouleau JL, Bonow RO (2006) Navigating the crossroads of coronary artery disease and heart failure. Circulation 114: 1202–1213

    Article  PubMed  Google Scholar 

  82. Kron IL, Green GR, Cope JT (2002) Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann Thorac Surg 74: 600–601

    Article  PubMed  Google Scholar 

  83. Buckberg GD and the RESTORE Group (2006) Form versus disease: optimizing geometry during ventricular restoration. Eur J Cardio thorac Surg 29: S238–244

    Article  Google Scholar 

  84. Di Donato M, Toso A, Dor V, Sabatier M, Barletta G, Menicanti L, Fantini F and the RESTORE Group (2004) Surgical ventricular restoration improves mechanical intraventricular dyssynchrony in ischemic cardiomyopathy. Circulation 109: 2536–2543

    Article  PubMed  Google Scholar 

  85. Stevenson LW, Rose EA, (2003) Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? Circulation 108: 3059–3063

    Article  PubMed  Google Scholar 

  86. Maybaum S, Mancini D, Xydas S, Starling RC, Aaronson K, Pagani FD, Miller LW, Margulies K, McRee S, Frazier OH, Torre-Amione G, The LVAD Working Group Cardiac Improvement During Mechanical Circulatory Support (2007) A prospective multicenter study of the LVAD Working Group. Circulation 115: 2497–2505

    Article  PubMed  Google Scholar 

  87. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Howard Frazier O, Desvigne-Nickens P, Oz MC, Poirier VL, Paul Meier P for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (2001) Long-term use of a left ventricular assist device for end-stage heart failure (REMATCH) Study Group. N Engl J Med 345: 1435–1443

    Article  PubMed  CAS  Google Scholar 

  88. Recommendations of the National Heart, Lung, Blood Institute Working Group on Future Directions in Cardiac Surgery (2005) Circulation 111: 3007–3013

    Article  Google Scholar 

  89. Buckberg GD (2003) Congestive heart failure: Treat the disease, not the symptom — return to normalcy. J Thorac Cardiovasc Surg 125: S41–S49

    Article  Google Scholar 

  90. Working Group on Cardiac Rehabilitation & Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology (2001) Recommendations for exercise testing in chronic heart failure patients. Eur Heart J 22: 37–45

    Article  Google Scholar 

  91. Haykowsky MJ, Yuanyuan Y, David Pechter D, Lee W, Jones LW, McAlister FA, Clark AM (2007) A metaanalysis of the effect of exercise training on left ventricular remodeling in heart failure patients. J Am Coll Cardiol 49: 2329–2336

    Article  PubMed  Google Scholar 

  92. Piepoli MF (2004) Exercise training meta-analysis of trials in patients with chronic heart failure (ExTra-MATCH). BMJ 328: 189–194

    Article  PubMed  CAS  Google Scholar 

  93. Rubin SA (2007) Exercise training in heart failure: contradictory or conventional? J Am Coll Cardiol 49: 2337–2340

    Article  PubMed  Google Scholar 

  94. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ (2006) Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48: 1527–1537

    Article  PubMed  Google Scholar 

  95. Pasic J, Levy WC, Sullivan MD (2003) Cytokines in depression and heart failure. Psychosom Med 65: 181–193

    Article  PubMed  Google Scholar 

  96. Herrmann-Lingen Ch, Binder L, Klinge M, Sander J, Schenker W, Beyermann B, von Lewinski D, Pieske B (2003) High plasma levels of N-terminal pro-atrial natriuretic peptide associated with low anxiety in severe heart failure. Psychosom Med 65: 517–522

    Article  PubMed  CAS  Google Scholar 

  97. Grippo AJ, Francis J, Weiss RM, Felder RB, Johnson AK (2003) Cytokine mediation of experimental heart failure-induced anhedonia. Am J Physiol Regul Integr Comp Physiol 284: R666–R673

    PubMed  CAS  Google Scholar 

  98. Scherer M, Himmel W, Stanske B, Scherer F, Koschack J, Kochen MM, Herrmann-Lingen C (2007) Psychological distress in primary care patients with heart failure: A longitudinal study. Br J Gen Pract 57: 801–807

    PubMed  Google Scholar 

  99. Jünger J, Schellberg D, Müller-Tasch T, Raupp G, Zugck C, Haunstetter A, Zipfel S, Herzog W, Haass M (2005) Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Failure 7: 261–267

    Article  Google Scholar 

  100. Bunzel B, Laederach-Hofmann K, Grimm M (2002) Überleben, klinische Daten und Lebensqualität 10 Jahre nach Herztransplantation: Eine prospektive Studie. Z Kardiol 91: 319–327

    Article  PubMed  CAS  Google Scholar 

  101. Inglis SC, Pearson S, Treen S, Gallasch T, Horowitz JD, Stewart S (2006) Extending the horizon in chronic heart failure: effects of multidisciplinary, home-based intervention relative to usual care. Circulation 114: 2466–2473

    Article  PubMed  Google Scholar 

  102. Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA (2007) Longterm survival after heart failure: a contemporary population-based perspective. Arch Intern Med 12: 490–496

    Article  Google Scholar 

  103. Hayes DL, Abraham WT (2006) Clinical trials — an overview. In: Yu CM, Hayes DL, Auriccio A (eds) Cardiac resynchronisation therapy. Blackwell-Futura Verlag, ISBN-13 978140 5142823, pp 239–256

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag/Wien

About this chapter

Cite this chapter

(2008). Literatur. In: Herzinsuffizienz. Edition Ärztewoche. Springer, Vienna. https://doi.org/10.1007/978-3-211-72021-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-72021-9_10

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-72020-2

  • Online ISBN: 978-3-211-72021-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation